“Although pharmaceutical companies spend over $172 billion on research and development annually, over 90% of molecules discovered using traditional techniques fail in human clinical trials.” AI may be the “Deux ex Machina” in the field of pharmaceutical R&D. Deep Knowledge Analytics publishes their list of AI companies that are solely dedicated to scientific R&D. (Forbes)